
Apollo Endosurgery APEN
Annual report 2022
added 03-30-2023
Apollo Endosurgery Total Current Liabilities 2011-2025 | APEN
Annual Total Current Liabilities Apollo Endosurgery
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 39.5 M | 14.5 M | 11.7 M | 52.8 M | 24.4 M | 25.8 M | 20.3 M | 1.08 M | 4.26 M | 3.53 M | 8.63 M | 10.1 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 52.8 M | 1.08 M | 18.1 M |
Total Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | ||
|
Abiomed
ABMD
|
129 M | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
18.9 M | - | -26.83 % | $ 2.62 M | ||
|
Apyx Medical Corporation
APYX
|
12.7 M | $ 3.83 | -0.91 % | $ 133 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
468 M | $ 306.74 | -0.45 % | $ 8.65 B | ||
|
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | ||
|
InMode Ltd.
INMD
|
69.9 M | $ 14.35 | -1.1 % | $ 1.14 B | ||
|
IRIDEX Corporation
IRIX
|
13 M | $ 0.99 | 7.52 % | $ 16 M | ||
|
Bruker Corporation
BRKR
|
1.28 B | $ 45.67 | 1.2 % | $ 6.8 K | ||
|
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | ||
|
Abbott Laboratories
ABT
|
14.2 B | $ 128.62 | 2.52 % | $ 224 B | ||
|
Boston Scientific Corporation
BSX
|
6.4 B | $ 91.86 | -0.78 % | $ 135 B | ||
|
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | ||
|
LivaNova PLC
LIVN
|
392 M | $ 63.33 | 0.92 % | $ 3.44 B | ||
|
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | ||
|
EDAP TMS S.A.
EDAP
|
37.8 M | $ 3.19 | 10.76 % | $ 119 M | ||
|
LENSAR
LNSR
|
15 M | $ 11.5 | -0.09 % | $ 132 M | ||
|
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
87.7 M | - | -10.19 % | $ 1.99 M | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | ||
|
Eargo
EAR
|
25.3 M | - | - | $ 10.2 M | ||
|
PAVmed
PAVM
|
54.2 M | $ 0.31 | -4.88 % | $ 2.24 M | ||
|
Dynatronics Corporation
DYNT
|
8.24 M | - | 14.99 % | $ 929 K | ||
|
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | ||
|
Cognyte Software Ltd.
CGNT
|
219 M | $ 9.6 | -2.64 % | $ 689 M | ||
|
Quanterix Corporation
QTRX
|
38.5 M | $ 7.5 | -0.86 % | $ 282 M | ||
|
IRadimed Corporation
IRMD
|
8.51 M | $ 97.18 | 0.99 % | $ 1.23 B | ||
|
Second Sight Medical Products
EYES
|
5.99 M | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
2.04 B | $ 163.64 | -1.08 % | $ 12.3 B | ||
|
Accuray Incorporated
ARAY
|
193 M | $ 1.05 | -0.94 % | $ 108 M | ||
|
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
10.4 M | $ 12.52 | -1.49 % | $ 338 M | ||
|
FONAR Corporation
FONR
|
16.7 M | $ 14.9 | 1.02 % | $ 97.7 M | ||
|
AxoGen
AXGN
|
30.6 M | $ 29.72 | -2.2 % | $ 1.32 B | ||
|
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | ||
|
GBS
GBS
|
5.35 M | - | -0.57 % | $ 7.12 M | ||
|
CONMED Corporation
CNMD
|
278 M | $ 40.32 | -1.26 % | $ 1.24 B | ||
|
OrthoPediatrics Corp.
KIDS
|
34 M | $ 17.74 | 0.8 % | $ 409 M | ||
|
Globus Medical
GMED
|
856 M | $ 86.69 | - | $ 11.8 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
922 M | $ 13.55 | 0.97 % | $ 1.04 B | ||
|
Aziyo Biologics
AZYO
|
43 M | - | 1.37 % | $ 20.5 M |